Nasdaq:US$15.15 (+0.04) | HKEX:HK$24.10 (-0.10) | AIM:£2.41 (+0.03)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor